iBio, Inc. (IBIO) vs Telomir Pharmaceuticals, Inc. (TELO)

iBio, Inc. and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. iBio, Inc. and Telomir Pharmaceuticals, Inc. are of similar size ($83.2M and $77.3M). Across the 9 metrics below, iBio, Inc. leads on 6 and Telomir Pharmaceuticals, Inc. on 3.

Valuation

Metric IBIO TELO Biotechnology median
P/E n/m n/m 7.88
P/S 183.45 n/m 11.47
P/B 1.44 14.75 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 55.05 n/m 10.73
Earnings yield (28.57%) (74.59%) (28.84%)
Free cash flow yield (19.57%) (6.62%) (23.03%)

Profitability

Metric IBIO TELO Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.70%) (1,885.50%) (57.72%)
Return on assets (54.04%) (1,678.31%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IBIO TELO Biotechnology median
Revenue growth (TTM) (66.55%) — 5.64%
EPS growth (last fiscal year) 81.71% 41.07% —
Revenue growth, 5-year CAGR (42.83%) — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IBIO TELO Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 7.85 16.14 4.73
Net debt to EBITDA 2.57 0.69 0.96

Dividend

Metric IBIO TELO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric IBIO TELO Biotechnology median
Market cap 77.28m 83.22m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack